Klacid Od

Clarithromycin, the active ingredient in Klacid Od, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and is incorporated into Helicobacter pylori eradication regimens, primarily in adult patients.

GNH USA supplies Klacid Od as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. It follows EU quality standards and provides regulatory‑approved batches for global distribution, with reliable logistics and compliance support for cross‑border procurement.

Clarithromycin is used to treat bacterial infections across several organ systems.

Community‑acquired pneumonia: eradicates the causative bacteria, leading to clinical recovery. Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms. Skin and soft‑tissue infections: clears Staphylococcus and Streptococcus species to promote wound healing. Helicobacter pylori eradication regimens: acts as part of combination therapy to achieve bacterial eradication and ulcer healing.

Clarithromycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Abdominal pain or discomfort - Altered taste sensation - Headache - Vomiting

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis - QT‑interval prolongation leading to cardiac arrhythmias - Hepatic dysfunction or jaundice - Clostridioides difficile‑associated colitis - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When prescribing Clarithromycin, clinicians should consider several precautionary measures to ensure safe use.

Assess liver function: evaluate hepatic enzymes before initiating therapy. Monitor cardiac QT interval: avoid use in patients with known QT prolongation or concurrent QT‑prolonging drugs. Use caution in renal impairment: adjust therapy based on renal function where necessary. Avoid in known macrolide hypersensitivity: discontinue immediately if allergic reaction occurs. Pregnancy and lactation: safety data are limited; prescribe only if benefit outweighs risk. Store below 25°C: keep in the original pack, protect from moisture and light.

Clarithromycin interacts with several medicines, requiring attention to avoid clinically significant effects.

Major Interactions (Avoid): - Concomitant use with other QT‑prolonging agents (e.g., cisapride, certain antiarrhythmics). - Co‑administration with drugs metabolized by CYP3A4 that have narrow therapeutic windows (e.g., simvastatin, lovastatin). - Use with pimozide or terfenadine: may cause serious cardiac events.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR; monitor coagulation parameters. - Oral hypoglycemics (e.g., sulfonylureas): may enhance hypoglycaemia; check blood glucose. - Theophylline and carbamazepine: may increase plasma concentrations; adjust dose if needed.